SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-042022
Filing Date
2020-07-09
Accepted
2020-07-09 18:26:43
Documents
1
Period of Report
2020-07-07

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 17829
  Complete submission text file 0001209191-20-042022.txt   19252
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Issuer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address C/O ACADIA PHARMACEUTICALS INC. 3611 VALLEY CENTRE DRIVE,SUITE 300 SAN DIEGO CA 92130
Business Address
YANG MICHAEL J. (Reporting) CIK: 0001702283 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50768 | Film No.: 201021343